LSIPR, Gowling WLG team up for biologics survey
Life Sciences IP Review has partnered with international law firm Gowling WLG to launch the Patent Litigation Survey to appraise the patent trends in biologics, biosimilars and next generation therapies.
SCOTUS won’t resuscitate Amarin’s Vascepa patents
Amarin has failed to persuade the US Supreme Court to consider reviving six patents on the heart medicine Vascepa, allowing generic drugmakers Hikma Pharmaceuticals and Dr. Reddy’s Laboratories to roll out copycat products.
Bio-Rad asks for review of DNA patent ruling
Bio-Rad has asked the US Court of Appeals for the Federal Circuit to review its prior decisions that affirmed Bio-Rad had infringed three 10X Genomics patents.
UC Berkeley gets $54k for T-cell patent NFT
The University of California Berkeley has sold a non-fungible token based on patent disclosures for Nobel Prize-winning cancer immunotherapies research at an online auction, netting approximately $54,360 from the sale.
No payday for GSK over stolen trade secrets
Two former GlaxoSmithKline researchers do not have to pay restitution for stealing the drugmaker’s trade secrets, a Pennsylvania court has ruled.
Cannabis firm asks court to consider new evidence in TM suit
A cannabis company has asked a district court to reconsider its summary judgment motion in a lawsuit over the trademark ‘Kiva’ in light of new evidence.
Allergan’s Forest to face jury in antitrust suit over Alzheimer drug
Allergan subsidiary Forest Laboratories will have to argue its case before a jury over claims that it used pay-for-delay deals to keep generic copies of blockbuster Alzheimer drug, Namenda, from the marketplace.
France backs COVID-19 vaccine IP waiver
French President Emmanuel Macron has committed to backing the proposal to waive IP rights for COVID-19 vaccines ahead of the G7 Summit taking place in England this weekend.
Brands urged to ‘cast a wide net’ for cannabis TMs: WIPR TM Live
Companies looking to enter the booming cannabis industry should “cast a wider net” when registering trademarks, according to a virtual panel discussion.
(WATCH) Lisa Ferri of Mayer Brown on the COVID-19 waiver
Talks over a COVID-19 vaccine waiver ended this week at the World Trade Organization in Geneva, with an agreement to work towards a text-based response to the plan.
